Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16186799rdf:typepubmed:Citationlld:pubmed
pubmed-article:16186799lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:16186799lifeskim:mentionsumls-concept:C1420020lld:lifeskim
pubmed-article:16186799lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:16186799pubmed:issue5lld:pubmed
pubmed-article:16186799pubmed:dateCreated2006-2-3lld:pubmed
pubmed-article:16186799pubmed:abstractTextThe v-rel oncogene is the most efficient transforming member of the Rel/NF-kappaB family of transcription factors. v-Rel induces avian and mammalian lymphoid cell tumors and transforms chicken embryo fibroblasts in culture by the aberrant regulation of genes under the control of Rel/NF-kappaB proteins. Here we report that the expression of SH3BGRL, a member of the SH3BGR (SH3 domain-binding glutamic acid-rich) family of proteins, is downregulated in v-Rel-expressing fibroblasts, lymphoid cells, and splenic tumor cells. Chromatin immunoprecipitation experiments demonstrated that v-Rel binds to the sh3bgrl promoter in transformed cells. Coexpression of SH3BGRL with v-Rel in primary splenic lymphocytes reduced the number of colonies formed by 76%. Mutations in the predicted SH3-binding domain of SH3BGRL abolished the suppressive effect on v-Rel transformation and resulted in colony numbers comparable to those formed by v-Rel alone. However, mutations in the predicted EVH1-binding domain of SH3BGRL only had a modest effect on suppression of v-Rel transformation. This study provides the first example of a gene that is downregulated in v-Rel-expressing cells that also plays a role in v-Rel transformation.lld:pubmed
pubmed-article:16186799pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:languageenglld:pubmed
pubmed-article:16186799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:citationSubsetIMlld:pubmed
pubmed-article:16186799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16186799pubmed:statusMEDLINElld:pubmed
pubmed-article:16186799pubmed:monthFeblld:pubmed
pubmed-article:16186799pubmed:issn0950-9232lld:pubmed
pubmed-article:16186799pubmed:authorpubmed-author:MauckH PHPlld:pubmed
pubmed-article:16186799pubmed:authorpubmed-author:BoseH RHRlld:pubmed
pubmed-article:16186799pubmed:authorpubmed-author:YonJJlld:pubmed
pubmed-article:16186799pubmed:authorpubmed-author:LissA SASlld:pubmed
pubmed-article:16186799pubmed:issnTypePrintlld:pubmed
pubmed-article:16186799pubmed:day2lld:pubmed
pubmed-article:16186799pubmed:volume25lld:pubmed
pubmed-article:16186799pubmed:ownerNLMlld:pubmed
pubmed-article:16186799pubmed:authorsCompleteYlld:pubmed
pubmed-article:16186799pubmed:pagination756-68lld:pubmed
pubmed-article:16186799pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:meshHeadingpubmed-meshheading:16186799...lld:pubmed
pubmed-article:16186799pubmed:year2006lld:pubmed
pubmed-article:16186799pubmed:articleTitleThe suppression of SH3BGRL is important for v-Rel-mediated transformation.lld:pubmed
pubmed-article:16186799pubmed:affiliationSection of Molecular Genetics and Microbiology, Institute of Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712-1095, USA.lld:pubmed
pubmed-article:16186799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16186799pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:5970entrezgene:pubmedpubmed-article:16186799lld:entrezgene
entrez-gene:6451entrezgene:pubmedpubmed-article:16186799lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16186799lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16186799lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16186799lld:pubmed